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Abstract 
 
A tryptic hydrolysis of whey protein isolate has generated 19 peptides from !-lactoglobulin 
source, out of 27 peptide sequences detected under HPLC-MS. Amongst 19 peptides, 12 were 
detected as anionic peptides and 5 as cationic peptides. The aim of this work was to 
investigate the process parameters for fractionating bioactive peptides from protein 
hydrolysate by pilot-scale electrodialysis with ultrafiltration membrane (EDUF) unit. 
Preliminary tests were performed to evaluate process parameters. A pressure-flow relation 
was studied for establishing no transmembrane pressure. Protein hydrolysate was fractionated 
during 60 minutes by EDUF on a pilot-scale EUR6 module. Under a constant pH of 6 and 
electric field strength of 0.7 V/cm, peptide migration rates of 0.57 ± 0.25!!/!!ℎ  and 0.29 ± 0.09!!/!!ℎ were achieved in anionic and cationic peptides recovery compartments 
respectively. An experiment was also further investigated under two electric field conditions: 
pulsed electric field (PEF) and reverse polarity (RP) to observe the effect on migration rate 
and selectivity. Total migration rates were found to be 0.51 ± 0.05 and 0.38 ± 0.15 !/!!ℎ 
under PEF and RP conditions, respectively. An application of PEF and RP were able to 
separate selectively few of peptides. Peptide migration rate and selective separation of 
peptides found to be strongly depended on electric field strength and pressure/flow rate in 
each compartment. It is the low electric field and relatively higher pressure that hinders the 
simultaneous separation of anionic and cationic peptides in their respective compartment. To 
our knowledge, it was the first attempt to study separation of bioactive peptides from whey 
protein isolate in a pilot scale EDUF module.   
 
Keywords: Whey protein hydrolysate, !-lactoglobulin, Bioactive peptides, Electrodialysis, 
Ultrafiltration membrane, Peptide fractionation. 
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1. Introduction  
1.1 Background and motivation  
 
The use of specific food for the prevention or treatment of diseases in human societies dated 
back to the ancient ages. Nearly 2500 years ago, Hippocrates stated, “let food be thy medicine 
and medicine be thy food.” In an ancient time, Indian sage Charaka worked with medicinal 
qualities of foods and herbs for healing the malfunctioning of the body, which is nowadays 
called Ayurveda [1]. In the modern society, there is increasing number of health problems 
like obesity, cancer and cardiovascular diseases which are related to the unhealthy dietary 
behaviors. Thus, there has been a widespread upsurge of interest among scientists in 
functional foods and nutraceuticals. Consumers have been increasingly oriented towards 
healthy foods with a consciousness of interrelation between diet and health. A food that 
contains bioactive ingredient such as oligosaccharides, minerals, polyunsaturated fatty acids 
and fibers are considered as functional foods. Therefore, bioactive compounds that are largely 
found in natural food and plant have been extensively studied.  
 
In the last decade, research has increased in the field of bioactive peptides from milk proteins. 
Such peptides cover a range of biological and physiological properties that may be important 
in development of new product of added value. This value added product could be used in 
replacement of synthetic drugs, particularly in the treatment of chronic diseases such as 
hypertension, cancer and obesity. Several reviews on bioactive peptides derived from the 
milk protein have been published recently. For instances, bioactive peptides produced from 
dairy [2] [3]; ACE inhibitory and opioid peptides from whey [4]. These peptides are encoded 
within the sequence of native protein. Various methods for isolation and production of 
bioactive peptides from their natural sources are attempted without losing its bioactivity. It 
may be generated in vitro by chemical and enzymatic hydrolysis. While enzymatic hydrolysis 
is more preferable because of high reaction specificity and reduced waste generation. 
Amongst other enzymes, hydrolysis with trypsin is the mostly used for generating peptides 
from whey protein since it produces wider range of bioactive peptides [3]. But these 
generated peptides are low in concentration and hence, their purification and concentration by 
various separation techniques are needed. 
 
Membrane processes showed a prominent role in the separation of bioactive peptides from 
hydrolysate. Several studies were reported on the use of enzymatic membrane reactors for the 
continuous production of protein hydrolysates and peptides separation [5],[6]. In addition, 
pressure driven processes like ultrafiltration and nanofiltration have also been used to study 
the separation of peptides based on their molecular sizes. A further enrichment of peptides 
has been reported by using stepped-UF method [7], where two different MWCO of 
membrane were used. However, most of the pressure-driven processes have significant 
limitations such as fouling and poor selectivity. It also lacks the simultaneous separation of 
cationic and anionic peptides since the pressure-driven separation is mostly governed by size 
difference than charge of peptides.  
 
Lapointe et al. (2005) reported the selective separation of cationic peptides from β-
lactoglobulin using electrical field in nanofiltration membrane. Later, a simultaneous 
fractionation of cationic and anionic peptides has been successfully achieved by Poulin et 
al.[8] using electrodialysis with ultrafiltration membrane (EDUF), a process patented by Dr. 
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Bazinet [9]. Laboratory scale-EDUFs have been successfully investigated for separation and 
isolation of various bioactive peptides like anticancer and antibacterial from snow crab 
byproducts, antidiabetic and antihypertensive peptides from flaxseed and antioxidant 
polyphenol from cranberry juice. Moreover, EDUF has an advantage of lower fouling 
compared to conventional pressure driven process and no change in selectivity due to cake 
layer formation. 
 
Despite of its wide application and perspective in the fractionation of bioactive peptides from 
various food sources, an industrial application of EDUF was still unexplored. In order to use 
EDUF successfully for an industrial application, an extensive study of process parameter on 
pilot scale is necessary. A scaling up of laboratory scale can be achieved by studying the 
influence of electric field strength, MWCO of ultrafiltration membrane (UFM), nature and 
conductivity of UFMs and configuration in pilot-scale. Different approaches of electric field 
conditions like reverse polarity (RP) and pulsed electric field (PEF) could be used for 
minimizing the fouling and scaling in the membrane and study the effect on membrane 
selectivity. A next step should account for the economic analysis of the process to be used 
commercially in a large-scale for the separation of bioactive compounds. This present work is 
to study a separation of peptides generated from tryptic hydrolysis of !-lactoglobulin using 
pilot-scale EDUF and observe the effect of various electric field on the performance of EDUF 
process. 
 
 
1.2 Research objectives 
 
As explained above, the aim of the present work is to produce peptides from an enzymatic 
hydrolysis of !-lactoglobulin and to investigate the feasibility of pilot-scale EDUF for the 
simultaneous separation of bioactive peptides using ultrafiltration membranes stacked in a 
batch recirculation process. The objectives of the current work were to: 
 
(i) perform a preliminary test on pilot-scale EDUF for establishing pressure-flow 
relation in each compartment, 
(ii) study the effect of electrodialytic parameters for the isolation of bioactive 
peptides from enzymatic hydrolysate of whey protein isolate and,  
(iii)  investigate the effect of electric fields on the performance of EDUF process, 
(iv)  characterize the peptides in feed hydrolysate and recovery compartments after 
EDUF process.  
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2. Literature Review 
2.1 Functional food and Nutraceuticals 
2.1.1 Definition 
 
The concept of functional foods has been widely spread as consumers are increasingly aware 
of the important link between diet and health. A balanced diet plays a vital role in combating 
chronic diseases and enhancing health. Thus an unbalanced diet and unhealthy eating habits 
have become major challenges in most of the countries around the world. It has caused a rise 
in conditions such as obesity, cancer, diabetes, cardiovascular diseases (CVD), osteoarthritis 
and allergies. For instance, 11 million people in the USA have type-2 diabetes [10]. 
Moreover, Soedamah-Muthu et al.[11] reported that cardiovascular diseases are the primary 
causes of death in the Western countries. 
 
Research in the field of functional foods and nutraceuticals has been extensively carried out 
in the recent years. According to the Institute of Medicine’s Food and Nutrition Board, 
functional food is defined as “any food or food ingredient that may provide a health benefit 
beyond the traditional nutrients it contains”. On the other hand nutraceuticals, as defined by 
Wildman (2000), “are naturally occurring substances in foods which have been found to be 
effective in the prevention of treatment of one or more diseases, or the improvement of 
physiological performance, thereby enhancing human health [12].” However there is yet no 
universal definition of functional food and nutraceuticals.  
 
As understood commonly, functional foods and nutraceuticals include the whole spectrum of 
foods with disease-preventive and health-promoting properties. Functional foods may be 
enriched with a specific health beneficial component, vitamin and mineral supplements, 
herbs, phytochemicals, and probiotics. Nutraceuticals can be derived from plant, animal, and 
microbial sources, including those from aquatic environment. Among various nutrients found 
from animal and plant sources, proteins have been broadly identified as sources of 
physiologically active peptides.  
 
 
2.1.2 Protein-precursor of bioactive peptides 
 
Bioactive peptides are those protein fragments that have a positive impact on body functions 
or conditions that may ultimately influence health. The bio-functionality of these peptides 
depends on their inherent amino acid composition and sequence. The size of peptides usually 
varies from 2 to 20 amino acids. These peptides are mostly inactive within the sequence of 
parent protein and can be released during gastrointestinal digestion or food processing. These 
bioactive peptides carry a wide range of biological, functional and nutritional properties. 
Depending on the amino acid sequence, these peptides may evoke numerous biological 
functions in vivo affecting, for instance, the cardiovascular, endocrine, digestive, immune and 
nervous systems. The beneficial health effects may further be classified as antimicrobial, 
antioxidant, antithrombotic, antihypertensive, antimicrobial or immunomodulatory, etc 
[13][14].  
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2.1.3 Bioactive peptides from milk 
 
Milk is a rich source of protein and also considered as an important source of bioactive 
peptides. Milk contains critical nutritive elements which are vital to both neonates and adults. 
Bioactive peptides can be produced from milk proteins through fermentation of milk, whey 
and ripened cheese. A considerable evidence of multifunctional capacities and bio-specific 
role of bioactive peptides from milk can be found in the literature ([15], [16], [17], [18]). An 
overview of primary classes of bioactive milk peptides, based on their specific physiological 
function and characteristics are presented in Table 2.1. Bioactive peptides evoke immune-
defense, neurological, physiological and vasoregulatory responses (Table 2.1).  
 
Table 2.1 Specific physiological function and characteristics of some bioactive milk peptides 
in milk. (adapted from Claire et al.[19]) 
No. Peptide sequence Name AA segment Physiological 
classification 
Release Protease Reference 
1 FFVAP αs1-Casokinin-5 αs1-CN (f 23–27) ACE inhibitor Proline 
endopeptidase 
[20] 
2 AVPYPQR β-Casokinin-7 β-CN (f 177–183) ACE inhibitor Trypsin [20] 
3 YGLF α-Lactorphin α-LA (f 50–53) ACE inhibitor and 
opioid agonist 
Synthetic peptide [21] 
4 ALPMHIR β-Lactorphin β-LG (f 142–148) ACE inhibitor Trypsin [22] 
5 KVLPVPQ Antihypertensive 
peptide 
β-CN (f 169–174) Antihypertensive 
peptide 
Lactobacillus CP790 
protease 
[23] 
6 MAIPPKKNQDK Casoplatelin κ-CN (f 106–116) Antithrombotic Trypsin & synthetic 
peptide 
[24] 
7 KDQDK Thrombin 
inhibitory 
peptide 
κ-CN glyco-
macropeptide (f 
112-116) 
Antithrombotic Trypsin [25] 
8 KRDS Thrombin 
inhibitory 
peptide 
Lactotransferrin (f 
39-42) 
Antithrombotic Pepsin [26] 
9 QMEAESISSS 
EEIVPNSVEQK 
Caseinophospho-
peptide 
αs1-CN (f 59-79) Calcium binding and 
transport 
Trypsin [17] 
10 LLY Immunopeptide β-CN (f 191–193) Immunostimulatory 
(+) 
Synthetic [27] 
11 FKCRRWQWRMK 
KLGAPSITCVRRA
F 
Lactoferricin B Lactoferrin (f 17–
41) 
Immunomodulatory 
(+) and antimicrobial 
Pepsin [28], [29] 
12 YQQPVLGPVR β-Casokinin-10 β-CN (f 193–202) Immunomodulatory 
(+/-) & ACE 
inhibitor 
Synthetic [30] 
13 RYLGYLE α-Casein 
exorphin 
αs1-CN (f 90–96) Opioid agonist Pepsin [31] 
14 YGFQNA Serorphin BSA (f 399–404) Opioid agonist Pepsin  [32] 
15 YLLF-NH2 β-Lactorphin β-LG (f 102–105) Opioid agonist and 
ACE inhibitor  
Sythetic or Trypsin [21] 
16 YIPIQYVLSR Casoxin C κ-CN (f 25–34) Opioid antagonist Trypsin [33] 
17 YVPF PPF Casoxin D αs1-CN (f 158–
164) 
Opioid antagonist Pepsin-
chymotrypsin 
[34] 
18 YLGSGY-OCH3 Lactoferroxin A Lactoferrin (f 318-
323) 
Opioid antagonist Pepsin [35] 
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In general, caseins and whey proteins are the two main groups of protein in bovine milk. Each 
of the sub-fractions found in casein or whey has its own unique biological properties. Caseins 
are sub-divided into !-, !- and !-caseins that comprises 80 percent of the total protein 
content in bovine milk. Whey comprises a heterogeneous group of proteins that remains in 
the supernatant after the precipitation of casein. Whey proteins are composed of ! -
lactoglobulin, !-lactalbumin, immunoglobulins (IgGs), glycomacropeptides, bovine serum 
albumin (BSA), and minor proteins such as lactoperoxidase, lysozyme and lactoferrin. These 
proteins have a compact globular structure. These proteins are dephosphorylated, insensitive 
to Ca2+ and easily denatured upon heating at temperature 90℃ [36]. Typical physico-chemical 
properties of whey protein are tabulated in Table 2.2. 
 
Table 2.2 Typical physico-chemical properties of whey protein (Adapted from Zydney et 
al,2000) 
Proteins Concentration (g/L) MW (kDa) Isoelectric point (pI) ! − !" 3-4 18.4 5.2 ! − !" 1.5 14.2 4.7-5.1 
BSA 0.3-0.6 69 4.7-4.9 
IgG, IgA, IgM 0.6-0.9 150-1000 5.5-8.3 
Lactoperoxidase 0.006 89 9.6 
Lactoferrin 0.05 78 8.0 
Protease-peptone 0.5 4-20  
Caseinomacropeptide  7  
 
 ! − !" is one of the major source of whey proteins used for the generation of bioactive 
peptides by microbial fermentation or enzymatic hydrolysis [3], [38]. Bioactivities of these 
peptides are encoded within the sequence of native protein precursors that can be generated in 
vitro by enzymatic hydrolysis which further can be purified by various separation techniques 
and assayed for bioactivity. Over the last decades, various proteases were used to produce 
bioactive peptides sequences from whey protein. The most commonly used protease for 
enzymatic digestion of ! − !" is trypsin. A tryptic digestion of  ! − !" can produce peptides 
sequences (f15-20, f102-105 and f142-148) which possess ACE inhibitory activity [22]. In 
addition to ACE inhibitory activity, trypsin can release hypocholesterolemic peptides [39] of 
sequence f71-75, bactericidal peptides [40] of sequence f15-20 and f92-100, and peptide 
sequence f102-105 having opioid activity [17]. These bioactive molecules are usually low in 
concentration and present in complex matrices, therefore it is necessary to use a suitable 
method for production and fractionation of these bioactive peptides of interest.  
 !
2.2 Production and fractionation of bioactive peptides 
 
There is increasing commercial interest in the production of bioactive peptides from various 
sources. There is a need to develop technologies which retain or even enhance the activity of 
bioactive peptides in food systems. 
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2.2.1 Production of bioactive peptides 
 
Biologically active peptides can mainly be produced from milk proteins by microbial 
fermentation of milk, direct synthesis & DNA recombinant technology and enzymatic 
hydrolysis. Amongst the various methods, enzymatic hydrolysis is the most commonly and 
widely used method for production of bioactive peptides from milk. Sometimes, a 
combination of these methods can be used to produce short bioactive peptides.   
 
2.2.1.1 Enzymatic hydrolysis 
 
Enzymatic hydrolysis is so far the most important and preferred method for the production of 
bioactive peptides. It involves proteolytic enzymes (also called proteases) for the digestion of 
native proteins to produce shorter peptides. There are several advantages of proteolytic 
hydrolysis over chemical hydrolysis [41] which are pointed below: 
i) defined product stereochemistry due to the high substrate and reaction specificity 
of  biocatalyst, 
ii) mild reaction conditions, and  
iii) reduced waste generation. 
 
The function of generated peptides from enzymatic hydrolysis mainly depends on the primary 
sequence of the protein substrate, the specificity of enzyme and digestive conditions. The 
digestive conditions of hydrolysis depend on pH, temperature, reaction time and degree of 
hydrolysis [42]. Trypsin, chymotrypsin, pepsin, alcalase, etc are some of the enzymes used to 
generate bioactive peptides from proteins. Amongst these enzymes, trypsin is the most widely 
used enzyme for digestion of protein from bovine milk. It is because of its tendency to 
generate more bioactive peptides even without combining with other enzymes (Weiter et al, 
1996). Whey proteins mainly containing β-lactoglobulin and α-lactalbumin are digested by 
trypsin to produce important bioactive peptides. Trypsin generated bioactive peptides from 
whey have not only ACE inhibitory properties but also antibacterial activity [22] and 
hyprocholesterolemic activity [39]. However hydrolysis of native proteins from whey leads to 
the formation of a complex mixture of peptides, non-hydrolyzed protein fraction and enzyme. 
In addition, the generated peptides after enzymatic hydrolysis are usually low in 
concentration. Therefore, an appropriate fractionation and purification method is important 
for recovery and concentration of peptides of interest for an industrial development. 
 
 
2.2.2 Separation and purification of bioactive peptides 
 
An efficient technique is crucial to separate and fractionate the bioactive peptides produced 
either from enzymatic hydrolysis or microbial fermentation method.  
 
2.2.2.1 Chromatographic techniques 
 
Novel membrane separation and ion-exchange chromatographic methods are employed by the 
emerging dairy ingredient industry. Chromatographic techniques (CTs) used mainly for 
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peptide purification are ion-exchange chromatography (IEC), size-exclusion chromatography 
(SEC), affinity chromatography, etc. CTs have advantages of higher sensitivity, purity and 
quality of final resultant product. These chromatography based techniques are found in 
industrial scale mostly in pharmaceuticals industry where high purity product is needed. 
However, it is limited to laboratory research purposes in food industry. Since they are very 
expensive, time consuming, applicable to only small sample volume and use a large quantity 
of solvents. Industrial-scale technologies suitable for the commercial production of bioactive 
whey peptides are consequently vital. Hence, a separation process that can be easily scaled-up 
for an industrial-scale at low cost using no or less solvent for the peptides separation and 
purification is needed. This need, therefore, can be achieved by using membrane-based 
processes.   
 
2.2.2.2 Pressure-driven membrane processes 
 
A number of membrane technologies have been developed and implemented in dairy 
processing since 1970s. Membrane separation processes were popular in a short span of time 
due to the fact that they are green technologies, use no solvent and need lower energy input in 
contrast to conventional methods. In a pressure driven membrane process, membrane pore 
size and size of particles are key factors since separation is based on size of particles applying 
a pressure gradient as a driving force. Pressure driven membrane separation processes include 
microfiltration (MF), ultrafiltration (UF), nanofiltration (NF) and reverse osmosis (RO). 
Among these, UF and NF are normally used for the separation of bioactive peptides from 
food and/or milk products.  
 
Enzymatic membrane reactors (EMRs) have been widely studied for the continuous 
production of protein hydrolysates and peptides. Hydrolysis has been carried out in batch or 
continuous process using different combinations of membrane reactors and ultrafiltration 
membranes. Several studies have been reported on the production of bioactive peptides. For 
instances, Visser et al. [6] investigated continuous production and isolation of peptide 
fractions from plasmin-degraded !-casein using enzyme recycled reactor. This process has 
limitation of operating for short period of time as membrane fouling and loss of enzyme 
activity were observed after longer conversion periods. In addition, Bordenave et al. [5] used 
an ultrafiltration EMR to concentrate β-lactoglubulin from goat’s whey and recover !-
lactalbumin derived peptides. β-Lactoglubulin was concentrated in the retentate while 
peptides from pepsin hydrolysis were obtained in permeate. They also suggested that a 
smaller molecular weight cut-off (MWCO) of membrane should be used for better 
fractionation of the peptides.  
 
Bouhallab et al. [43] observed the effect of UF membrane area and their nature when stirred-
tank membrane reactor (STMR) was used for the extraction of an immunomodulatory peptide 
from a bovine !-casein using chymosin as protease. They observed that feasibility of the 
process mainly depends on UFM area and its nature. Membrane recycled reactor was applied 
by Perea et al.[44] to hydrolyze whey proteins by alcalase considering to obtain higher 
conversion and productivity compared to batch process. However they found that the main 
limitation with this process was the membrane fouling resulting in reduction of productivity. 
Similarly, other researches were carried out using an immobilized enzyme reactor for partial 
hydrolysis of whey protein concentrate on controlling the degree of hydrolysis (DH), below 
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10% to minimize bitterness of hydrolysates. The resulting product contained a mixture of 
protein and peptides with lower ACE inhibitory activity. However, the main limitations of 
using membrane reactors employing UFM were membrane fouling with a subsequent 
decrease in productivity.  
 
In order to use peptides as nutraceuticals, further purification and fractionation of 
hydrolysates will be required. In the literature, the enrichment of peptides has been found to 
be carried out mainly by ultrafiltration methods. Turgeon et al. [7] utilized a stepped UF 
method to limit the range of peptides to the narrow range. They used ultrafiltration membrane 
with MWCO of 1 and 30 kDa to enrich ACE inhibitory peptides from !-lactoglobulin and !-
lactoglobulin. Gauthier and Pouliot (2003) employed a two-step ultrafiltration process; in the 
first step using 30 kDa membrane and second step using 1 kDa NF membrane for non-
hydrolyzed protein separation and peptides fractionation respectively. Similarly, Butylina et 
al. [45] also used a combination of UF and NF for the peptides fractionation from sweet 
whey; first step to retain completely the whey proteins from sweet whey incorporating 
ultrafiltration membrane of MWCO of 10 kDa, while the resulting permeate fractions were 
fractionated by nanofiltration with MWCO of 1 kDa. 
 
In previous studies, it was observed that ultrafiltration, nanofiltration and sometimes their 
combination were extensively used for the purification and fractionation of bioactive 
peptides. It was also evident that UF and NF significantly lead to a problem of membrane 
fouling and poor selectivity when fractionating peptides of similar sizes [46]. Bioactive 
peptides fractionation depending on the size was possible with pressure driven process, but it 
lacks the ability to separate peptides according to their charges.  
 
 
2.2.2.3 Electromembrane Processes  
 
Electromembrane processes are one of the innovative fractionation methods and include 
electrofiltration, which consists of the application of an electrical field in order to further 
improve and exploit separation by charge difference. It addressed the lacking of peptides 
separation depending on its charge and significant fouling on UF and NF membrane observed 
in pressure-driven processes. Peptides fractionation by electromembrane procedure involves a 
concept of transport of charged peptides by using electrical field.  
 
In 1999, Recio and Vesser [47] used laboratory-scale ion-exchange membrane for the 
separation of lactoferrin from whey proteins. They achieved a yield of 50%, but it took 24 
hours to complete and found to be limited for scalability of this process. Lapointe et al. [48] 
exploited the application of electrical field in nanofiltration membrane for selective separation 
of cationic peptides from a tryptic hydrolysate of β-lactoglobulin. However this method lacks 
an electrolyte recirculation compartment that could prevent pH changes caused by electrolysis 
of water at the electrodes. This could lead to bioactive peptides susceptible to oxidation when 
comes in contact with electrodes [49].  
 
An innovative method “electrodialysis with ultrafiltration membrane” (EDUF) for the 
separation of bioactive peptides has recently been emerged and patented by Bazinet et al. [9]. 
EDUF is a batch process which allows the migration of molecules according to their charges 
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and molecular weights, where migration of peptides are solely driven by applied electric field. 
EDUF configuration consists of ultrafiltration (UFM) and ion-exchange membranes (IEM) 
stacked in a conventional electrodialysis (ED) cell. Therefore, EDUF process combines the 
charge selectivity of conventional ED process with size exclusion characteristic of UF 
membranes [49]. A typical EDUF cell is generally composed of a feed solution compartment 
corresponding to the solution to be separated and two recovery compartments for anionic 
(!!"! ) and cationic peptides (!!"! ) which contain a salt solution (KCl) for electrical current 
circulation. The same or different MWCO of UFMs can be placed in between ion exchange 
membranes [50]. There is no transmembrane pressure (TMP) applied during this process.  
 
This technology has been found effective in numerous potential applications in the food and 
bio-pharmaceutical industry for the separation and the recovery of bioactive compounds. 
Poulin et al. (2006) studied a laboratory-scale EDUF for the simultaneous separation of 
bioactive peptides from β-lactoglobulin hydrolysate using a configuration of one UFM (20 
kDa) between two IEM. Among 40 peptides present in the hydrolysate, 13 peptides were 
selectively fractionated in different compartments of EDUF cell based on their charges [8]. 
More recently, Doyen et al. (2011) used two UFMs between IEMs where they reported an 
anticancer peptide fraction from snow crab byproduct hydrolysate after a selective separation 
by EDUF with 20 kDa MWCO ultrafiltration membrane. In another study of Doyen et al. 
(2012), they used two different MWCO of UF (20 kDa and 50 kDa) under electric field 
strength of 2 and 14 V/cm to recover and concentrate an antibacterial fraction from the snow 
crab byproduct hydrolysate. In the study made by Roblet et al (2013), it is found that pH 
modulation can bring an efficient way to concentrate the low molecular weight peptides of 
400 Da in the cationic recovery compartment and to limit the diversity of peptides recovered 
in the anionic peptides recovery compartment. They studied under three controlled pH 
conditions of 3, 6 and 9. 
 
When compared to conventional technologies, EDUF has many advantages like: (a) it is a 
green technology since no solvent is used, (b) high selectivity of the process since it separates 
bioactive peptides based on size/charge in one operation, (c) reduced membrane fouling when 
charged molecules are only allowed to pass through membrane under applied electric field, 
unlike pressure driven process, (d) scale-up is simpler by stacking membranes according to 
the required production and (e) it can be easily integrated with an existing industrial 
production line. 
 
EDUF technique has showed potential applications for diverse raw matrices, mainly for the 
separation and purification of bioactive peptides/compounds. Until now EDUF has 
demonstrated its novelty to fractionate several bioactive compounds such as antioxidant 
peptides from soy-protein hydrolysate [46], chitosan oligomers [51], [52], antihypertensive 
peptide from alfalfa white protein hydrolysate [53], antioxidant polyphenols from cranberry 
juice [54]–[56], antidiabetic and antihypertensive peptides from flaxseed protein hydrolysate 
[57]. It proved the versatility of EDUF technology is not only limited to separation of 
bioactive compound from protein source but also from other food sources.  
 
However, a deterioration of process performance due to membrane fouling is a frequently 
observed problem. As a result, electrodialysis system are often operated in reverse mode, 
where the polarity of the electrodes is reversed to change the direction of ion movement [58], 
[59]. Another method so-called pulsed electric field (PEF) is nowadays being used for 
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minimizing the effect of membrane fouling and scaling. Successful uses of PEF for reducing 
membrane fouling were reported by Ruiz et al.[60] for protein deposit and Cifuentes-Araya et 
al.[61] for scaling.  
 
EDUF has been successfully used in the basic laboratory research for bioactive molecules 
separation and purification. However, scale-up of laboratory scale for an industrial 
application has not yet been fully examined. Pilot-scale study should be studied to investigate 
the process parameters before testing an EDUF system at a large scale to carry-out a complete 
economic analysis of the process.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Confidential+Report+ + ++++!13 
 
 
 
 
 
 
 
CHAPTER(3(
MATERIALS(AND(METHODS(!!!!! !!!!!!!!!!!!!!!!!!
 Confidential+Report+ + ++++!14 
3. Materials and Methods 
3.1 Materials 
3.1.1 Chemicals 
 
BiPro, whey protein isolate containing bovine beta-Lactoglobulin (!-Lg) with ≥90 % purity 
was purchased from Davisco (MN, USA) and bovine pancreatic trypsin, with an activity 
equal to 11,680 BAEE (!"-Benzoyl-L-Arginine-Ethyl-Ester) unit per mg proteins from 
Sigma-Aldrich (St. Louis, MO, USA). One BAEE unit produces Δ!!"# of 0.001 per minutes 
in 3.2 mL at pH 7.6 at 25 ℃. HCl, NaOH and NaCl were obtained from Fischer Scientific 
(Montréal, Canada). KCl was provided by VWR International and Na2SO4 by Anachemia 
Canada Co. (Montréal, Canada).  
 
3.1.2 Membranes 
 
Polyether Sulphone (PES) ultrafiltration membranes (UFMs) with molecular weight cut-off 
(MWCO) of 100 kDa were purchased from Synder Filtration (USA). Neosepta CMX-SB 
cationic membranes (CEM) and Neosepta AMX-SB anionic membranes (AEM) were 
provided by Tokuyama Soda Ltd. (Tokyo, Japan). The physicochemical properties of 
membranes are enlisted in Table 3.1. 
 
Table 3.1 Physicochemical properties of membranes. 
 
Type of 
membrane used 
 
Physicochemical properties 
 
Thickness 
(mm) 
 
Conductivity 
(mS/cm) 
AEM 0.14 9.20 
CEM 0.17 12.06 
UFM 0.177 ± 0.002 5.88 ± 0.200 
 
 
3.2 EDUF cell configuration 
 
The electrodialysis cell used in this experiment was an EUR6 model, manufactured and 
configured by Eurodia with a total effective surface area of 0.734 m2. Electrodialysis with 
ultrafiltration (EDUF) cell consisted of 13 stacks each containing two UFMs sandwiched 
between ion-exchange membranes (IEMs) as shown in Figure 3.1. Both electrodes (anode 
and cathode) were made of nickel. A closed flow circulation was maintained with four 
external compartments using four centrifugal pumps with four external reservoirs. The cell 
was configured for a simultaneous separation of anionic and cationic peptides. A 3L of feed 
solution (hydrolysate of BiPro, 10 g/L) in feed compartment was circulated between two 
UFMs with filtration side facing towards the feed compartment. Next two compartments, 
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each containing 3L of KCl solution (2 g/L) were dedicated to the recovery of anionic !!"!  
peptides and cationic !!"!  peptides. The last compartment (electrolyte compartment) for the 
electrode rinsing solution contained 3L of Na2SO4 (20 g/L).  
 
 
 
Figure 3.1 EDUF cell configuration for the simultaneous separation of anionic and cationic 
peptides. AEM: anion-exchange membrane, UFM: Ultrafiltration membrane, 
CEM: cation-exchange membrane, !!: cationic peptides, !!: anionic peptides, !!: neutral peptides. 
 
 
3.3 Protocols 
3.3.1 Hydrolysis of BiPro 
 
Hydrolysis of BiPro was carried out in two batches of 20 L. 250 g of BiPro were dissolved in 
20L of distilled water maintaining pH 7.8 and left overnight at 4℃. The day after, enzymatic 
hydrolysis was initiated by adding 100 mL of trypsin solution (25 g/L) at controlled 
temperature of 37℃ in a double jacket reservoir (Scanima a/s, Aalborg, Denmark) while 
adjusting pH at 7.8 by adding 1N NaOH throughout an experiment of 120 minutes. The 
trypsin solution was prepared by weighing 2.5 g of trypsin in 100 mL of milli-Q water 
(conductivity ≤ 18.2!"/!"). After 120 minutes of enzymatic hydrolysis, tryptic action was 
inactivated by rising the temperature to 80℃ for 30 minutes. Then the final hydrolysate was 
freeze-dried and stored at 4℃. 
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3.3.2 Preliminary tests 
 
Preliminary tests were carried out with three cases to optimize the operational parameters. An 
overview of the preliminary tests is outlined in Table 3.2. The first two cases were done 
without applying any voltage in order to observe the effect of flow rate with pressure at 
different temperature in EDUF cell. Case I: All compartments were filled with de-ionized 
water. Case II: An aqueous KCl solution (2 g/L, 3 L) was taken in both feed and permeate 
compartments and Na2SO4 (20 g/L, 3L) as an electrode rinsing solution. Both cases were 
performed at three different temperatures (37℃, 27℃ and 17℃ ) and the corresponding 
pressure was noted with increasing flow rate from 0.75 L/min to 3 L/min. Case III: A limiting 
current density was determined according to the method described by Cowan and Brown [62] 
and it was found to be 0.43 A/m2. This preliminary test was done with 10 g/L of BiPro 
hydrolysate solution (3 L), 2 g/L KCL solution (3 L) and 20 g/L Na2SO4 aqueous solution 
(3L) in feed, peptides recovery and electrolyte compartment respectively. The initial pH of 
feed solution was manually fixed to 6 by addition of HCl (0.1 N) and a constant electric field 
of 0.7 V/cm was applied between the two electrodes. The pressure of 10 psi was maintained 
in recovery and feed compartments to avoid transmembrane pressure in the cell. The 
experiment was run at room temperature and changes afterward were recorded. 1.5 mL 
samples were collected from the feed and recovery compartments before applying the voltage 
and every ten minutes during the experiment of one hour. Current intensity, pH, conductivity 
and temperature were recorded every ten minutes all along the treatment. The conductivity 
and pH were controlled by KCl solution (100 g/L) and NaOH solution (1 N) or HCl solution 
(0.1 N), respectively. A constant electrode solution flow rate of 4 L/min and pressure of 4 psi 
was kept for all preliminary cases. Three replicates of each experimental condition were 
performed. 
 
Table 3.2 Preliminary tests done with different test solutions at various experimental 
conditions. 
 
Cases 
Test Solution in different compartments Experimental conditions 
Feed Recovery Electrolyte Voltage Temperature 
I DI water DI water DI water NA 17, 27 & 37℃ 
(3 replicates 
each) 
II KCl solution 
(2 g/L, 3L) 
KCl solution 
(2 g/L, 3L) 
Na2SO4 
solution (20 
g/L, 3L) 
NA 17, 27 & 37℃ 
(3 replicates 
each) 
III Hydrolysate 
(10 g/L, 3L) 
KCl solution 
(2 g/L, 3L) 
Na2SO4 
solution (20 
g/L, 3L) 
10 Volts Room 
temperature=27℃ 
(3 replicates) 
DI water: de-ionized water, NA: not applied 
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3.3.3 Electroseparation procedure 
 
Three different experimental conditions were assessed namely, Direct Current (DC), Pulsed 
Electric Field (PEF) and Reverse Polarity (RP) to study the effect on migration rates of 
anionic and cationic peptides in EUR6 cell. The procedure for the three conditions were 
followed as described in abovementioned case III of preliminary tests except the conductivity 
of feed solution which was made equal to the permeate compartment by adding 3 g of NaCl 
solution. A calibration curve of NaCl conductivity as a function of concentration was plotted 
(shown in Figure 3.2). In this condition the limiting current density was found to be 0.553! ± 0.026!!/!!. EDUF was carried out by using constant voltage of 10 V using a 
Xantrex power supply (Model HPD 60-5SX; Burnaby, BC, Canada). A pulse/pause of 2s/0.2s 
(ratio=10) was applied for PEF and a current application duration of 2s and reverse polarity 
(RP) of 0.2s was applied for RP. The RP and PEF generation was generated using a one mode 
generator (Pulsewave 760, Bio-rad, USA). Three replicates of each condition were 
performed. Membrane cleaning was done with demineralized water between two replicates 
while complete acid-base-acid cleaning was performed before starting third replicate.  
 
 
Figure 3.2 Calibration curve of conductivity as a function of NaCl concentration at room      
temperature. 
 
 
 
3.4 Analysis method 
3.4.1 Solution conductivity 
 
The conductivity of feed and permeates (!!"!  and !!"! ) was measured using a YSI 
conductivity meter (Model 3100) equipped with an automatic temperature compensation 
(ATC) YSI immersion probe model 3252, cell constant K= 1 cm-1 (Yellow Springs Inc, OH, 
USA). 
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3.4.2 pH 
 
A pH-meter model SP20 (Thermo Orion, West Chester, PA, USA) with a VWR Symphony 
epoxy gel combined pH electrode (Montréal, Canada) was used. 
 
3.4.3 Total peptide concentration determination in liquid samples 
 
The total peptide migration in !!"!  and !!"!  was determined using BCATM protein assay 
(Pierce Biotechnology Inc., Rockford, IL, USA) for all conditions. Samples were prepared in 
96 wells microplate (Corning Inc. NY, USA) and incubated at 37℃ for 30 minutes and then 
cooled at room temperature. The absorbance was read at 562 nm on a microplate 
spectrophotometer (THERMOmax, Molecular devices, Sunnyvale, CA). The concentration of 
anionic and cationic peptides was determined with a standard calibration curve in a range of 
25-2000 !"/!" of bovine serum albumin (BSA).  
 
3.4.4 Determination of total peptides in freeze dried sample 
 
The initial protein concentration of BiPro before and after hydrolysis was determined by the 
total nitrogen determination in the samples. Total nitrogen content in the sample was 
analyzed by combustion of 150 mg sample using a LECO-FP528 carbon and nitrogen 
analyzer (LECO, St. Joseph, Michigan, USA). Nitrogen content in the samples were 
converted into protein percentages by multiplying with a conversion factor of 6.38 that is the 
value commonly used for milk proteins [63]. 
 
3.4.5 Protein and peptide profiles 
 
The peptide composition of the initial hydrolysate, !!"!  and !!"!  was determined by RP-
HPLC according to the method of Firdaous et al. [53] which is adapted to the specific 
conditions of the !-Lg and peptides generated during enzymatic hydrolysis. A sample for 
analysis was prepared in a 2 ml vial with 0.2 !" PVDF (Canadian Life Science, ON, 
Canada) filter before passing into system. The system used was an Agilent 1100 series. 
Peptides were analyzed with a Luna 5 !" C18 column (2 i.d. × 250 mm, Phenomenex, 
Torrance, CA, USA). Trifluoroacetic acid (TFA) 0.1% (v/v) in water as solvent A and 
acetonitrile/water/TFA (90%/ 10%/ 0.1% (v/v)) as solvent B were used for elution at a flow 
rate of 0.2 mL/min. A linear gradient of solvent B, from 3% to 55% in 85 min was used. 
Peptide elution was monitored at a wavelength of 214 nm [53], [64]. 
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4. Results and Discussion 
4.1 Preliminary tests 
4.1.1 Pressure as a function of the flow rate (Case I and Case II)  
 
As mentioned in Table 3.2, different solutions were tested to verify the relationship between 
flow rate and pressure in each compartment (Figure 4.1b) of the cell as a function of 
temperature. Despite of test solutions used, a linear relation between the pressure and flow 
rate was observed in each compartments at different temperatures. It is observed that the 
pressure obtained for the respective flow rates in each compartments were slightly higher 
when test was done with water than KCl solution; 9.56 versus 8.70 psi/L.min-1, 6.84 versus 
6.04 psi/L.min-1 and 5.75 versus 5.56 psi/L.min-1 for feed, !!"!  and !!"!  compartments 
respectively. A test done by either solutions (water or KCl) had higher slope in feed 
compartment than recovery compartments (slope=9.56 with respect to 6.84 and 5.75 for water 
and slope=8.70 with respect to 6.04 and 5.56 for KCl)  which means a respective pressure can 
be achieved at lower flow rate in feed compartment than recovery compartments. It is also 
seen that the slope is quite similar (5.75 for water and 5.56 for KCl) in !!"!  for both case. 
During the test it was noted that the flow rate in feed compartment cannot be increased after 
attaining certain maximum value; 19 psi at 2.2 L/min for water and 16 psi at 1.8 L/min for 
KCl.  
 
It was also noticed that there was not a significant effect of temperature in the relation of 
pressure and flow rate in each compartment. However, the different pressures were observed 
for the same flow rate in the feed and recovery compartments. At flow rate of 2 L/min, a 
pressure of 17.5, 12 and 9.6 psi was observed in the case of water solution for feed, !!"!  and !!"!  compartments respectively. Similarly, in the case of KCl solution, a pressure of 14, 9.5 
and 7.5 psi was found at 1.5 L/min for feed, !!"!  and !!"!  compartments respectively. The 
variation in compartmental pressure can be explained due to the presence of different 
membranes in the configuration and their tendency of loss of charge. Feed stream passes 
through two ultrafiltration membranes. Ultrafiltration membranes used were asymmetric 
membrane (as shown in Figure 4.1a). The filtering side of UFMs is smoother than non-
filtering side and it is assumed that the presence of roughness in non-filtering side affects the 
flow tendency along the membrane (Suwal et al, 2014). Consequently, this leads to a loss of 
charge and impact the flow-pressure relation in the compartments. The difference in 
compartmental pressure may also be due to the compactness of membranes, that is uneven 
inter-spacing among the membranes.  
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!
Figure 4.1a A schematic representation of non-symmetric UFM. 
 
Furthermore, it was preferred to maintain the same pressure in feed and recovery 
compartments to avoid the formation of a transmembrane pressure (TMP). Therefore, the 
mean pressure of 10 psi was chosen to avoid bubble formation inside the tube of solution 
flow (in case of lower pressure) and to minimize the external leakage from the cell (in the 
presence of higher pressure). A room temperature was chosen considering no significant 
effect of temperature in pressure and flow relation which can also minimize the energy cost. 
The flow rates required to maintain the pressure of 10 psi at 27℃ (room temperature) in feed, !!"!  and !!"!  compartments were found to be 1.08! ± 0.02, 1.63! ± !0.10 and 2.00! ± 0.05 !.!"#!! respectively.  
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(a) Water (d) KCl 
 
 
 
 
(b)  (e)  
 
 
 
 
(c)  (f)  
  
 
 
Figure 4.1b Evolution of pressure as a function of flow rate in feed compartment (a,d), !!"!  
(b, e) and !!"!  (c, f) done only with de-ionized water (a, b, c) and KCl solution (d, 
e, f) at temperature, T= 37 , 27 and 17℃. !!"! : anionic peptides recovery 
compartment, !!"! : cationic peptides recovery compartment. !!!
Feed!co
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4.1.2 Preliminary tests to study electrodialytic parameters (Case III) 
 
The section below described the preliminary experiments carried out with BiPro hydrolysate 
as feed solution. A constant pressure of 10 psi was maintained by adjusting the respective 
flow rates for different compartments as discussed in the previous section (4.1.1). 
 
4.1.2.1 Limiting current density 
 
I-V curve (Figure 4.2) was used to find the limiting current density for these conditions of 
experiment. The limiting current density was found at 12 V. The experiment was carried out 
under the limiting current density at 10 V to avoid water-splitting which has a consequence in 
energy loss due to water splitting rather than ion transport. In addition, water splitting can 
change in pH of respective compartment, increase in membrane resistance and change in 
membrane properties, for instance, OH- can degrade AEM.  
A constant pH (data not shown) observed in the feed compartment during the experiment also 
revealed that the applied current was smaller than limiting current density [65].  
 
 
 
Figure 4.2 I-V curve for determining limiting current density.  
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4.1.2.2 Evolution of current intensity 
 
Figure 4.3 showed the current intensity increased linearly (R2=0.9979), from initial average 
value of 0.23! ± 0.02!! to final average value of 0. 33! ± 0.01!!, during the experimental 
period of 60 minutes.  
 
 
Figure 4.3 Change in current intensity with time during experiment of 60 minute at pH 6 and    
T= 27℃. 
 
4.1.2.3 Solution electrical conductivity 
Figure 4.4 represents the changes in solution electrical conductivity in feed (Figure 4.4a) and !!"!  compartments (Figure 4.4b) during the 60 minutes of EDUF treatment. The solution 
conductivity increased linearly in feed (R2=0.994) and !!"!  (R2=0.951) compartments: 
conductivities increased significantly as a function of time from 0.93 ± 0.11 to 1.85 ± 0.08 
mS/cm (slope= 0.97) and from 2.49 ± 0.16  to 3.00 ± 0.13  mS/cm (slope= 2.43), 
respectively, while it decreased in !!"!  (data not shown) soon after the voltage was applied to 
EDUF cell. The conductivity in !!"!   was maintained constant at initial value of 2.33 ± 0.05 
mS/cm by adding KCl solution (100 g/L) as explained by Suwal et al.[66] since it does not 
allow increase in local resistance in the cell. In contrast, Poulin et al.[8] has found that the 
conductivity of !!"!  decreased over time, regardless the number of stacks used. Unlike the 
current configuration, Poulin et al. [67] had used one UFM (20 kDa) sandwiched between 
two IEMs that resulted in demineralization of the !!"!  compartment at pH 5. Doyen et al.[68] 
also reported the decrease in !!"!  conductivity using two UFM (50 kDa) sandwiched between 
two IEMs at pH 7.8. Though the electrodialytic parameters were different between present 
and previous studies but the difference in conductivities of feed and recovery compartment 
mainly can be described with respect to cell stacking.  In this study, the configuration of 
EDUF cell with 13 repetitions of the stack was used while the previous study was made with 
one single unit. Figure 6 also showed that the conductivity in feed increased by two-fold 
compared to !!"!  than their respective initial value. This can be explained since two ions (!! 
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and !"!) migrated to feed compartment from !!"!  and !!"!  compartments respectively, while 
only !"!  ion remains in !!"!  since it could not pass through the CEM resulting in its 
accumulation and hence to an increase in conductivity. This is also the reason of the increase 
in current intensity (Figure 4.3) with time during EDUF treatment. 
          (a) 
(b)  
 
Figure 4.4 Evolution of conductivity in feed (a) and !!"!  compartment (b) during 60 min- 
EDUF   treatment at pH 6, constant voltage of 10 V and at room temperature. !!
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4.1.2.4 Evolution of peptide concentrations in !!"!  and !!"!  recovery compartments 
 
Figure 4.5 represents the concentration of peptides in  !!"!  and !!"!  compartments. The 
peptides concentration in both compartment increased during the treatment of 60 minutes.  
However the final concentration of peptides in !!"!  is two-fold higher than in !!"!  with values 
of 196.7 ± 86.7!!"/!" and 84.8 ± 26.9!!"/!" respectively which correspond to peptide 
migration rates of 0.57 ± 0.25!!/!!ℎ  and 0.29 ± 0.09!!/!!ℎ . The difference can be 
explained by the fact that a tryptic hydrolysis of !-Lg generates mostly anionic peptides at pH 
7.8 [68][69][70] which induces rapid and higher migration rates. Furthermore, the membrane 
and peptides interaction can also influence the migration rate of peptides. Since the charge of 
the peptides and membrane surface varies according to the experimental pH. Following these 
results, a further experimental design was developed to study the effect of electric field 
conditions, DC, PEF and RP on EDUF peptide migration rates.  
 
 
Figure 4.5 Concentration of anionic and cationic peptides as a function of time at pH 6, 
constant voltage of 10 V and at room temperature. 
 
 
4.2 Effect of application of PEF and RP conditions on peptide migration and selectivity 
4.2.1 I-V curve !
Figure 4.6 shows the current intensity as a function of voltage before performing an 
experiment under the conditions of DC, PEF and RP. The limiting current density is observed 
once again at 10 V. It is due to the presence of electric field as a driving force that reduced the 
possibility of deposition of uncharged peptides on UFMs unlike the pressure driven processes 
[8]. Hence, it theoretically means that there was no membrane fouling. As a result, the 
limiting current density was unchanged even after three repetitions of each condition were 
carried out.  
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Figure 4.6 I-V curve before performing DC, PEF and RP experimental conditions. DC: direct 
current, PEF: pulsed electric field, RP: reverse polarity. 
 
 
4.2.2 Evolution of conductivities  
 
Whatever the experimental conditions, the conductivity in feed solution increased linearly 
with time as shown in Figure 4.7a. 3 g of NaCl was added in feed compartment before 
starting the experiments in order to increase the initial feed conductivity. Addition of salt in 
feed also increased the initial current intensity due to the global distribution of conductivity 
through the feed channels and hence to maintain the constant electric field. As the treatment 
proceeded the conductivity in feed compartment linearly increased during the 60 min 
treatment under DC (R2=0.9806), PEF (R2=0.9886) and RP (R2=0.9834) conditions. The 
increase in feed conductivity can be explained as previously by !! and !"! migration into 
the feed compartment from !!"!  and !!"!  compartments, respectively. The same tendency had 
been found by Doyen et al. [68] even when a single unit was used. Nevertheless, the final 
feed conductivities for DC, PEF and RP were 3.27 ± 0.49, 2.74 ± 0.02 and 2.65 ± 0.06 
mS/cm respectively, but the conductivity is half time higher in DC than PEF and RP. The 
reason of slower increase in conductivity is due to the pulse and pause effect generated by 
PEF and reversing the polarity in RP condition. Also, it can be seen in Figure 4.7a where the 
linear plot of PEF and RP are not so apart with no such significant changes through the 
treatment period. As a result the movement of ions from recovery compartment to feed 
compartment are controlled in the case of PEF and RP. 
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(a) 
 
(b) 
 
 
Figure 4.7 Evolution of conductivity in feed (a) and !!"!  compartment (b) under DC, PEF 
and RP experimental conditions at pH 6. !!"! : anionic peptides recovery 
compartment, DC: direct current, PEF: pulsed electric field, RP: reverse polarity. 
 
 
The change in conductivity in anionic recovery compartment during the treatment of 60 min 
is shown in Figure 4.7b. The conductivity in anionic recovery compartment increased rapidly 
compared to feed compartment. Likewise the conductivity in feed compartment, the final 
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conductivity under DC current is higher than PEF and RP in anionic recovery compartment. 
The final conductivity under DC, PEF and RP conditions are reported as 3.76 ± 0.17, 3.34 ± 0.53 and 3.42 ± 0.18 mS/cm, respectively. The rapid increase in conductivity in 
anionic recovery compartment can be explained by obstruction of movement of Cl- ion from 
the feed compartment towards the counter electrodes but the presence of CEM on pathway 
retained the Cl- in anionic recovery compartment. However the PEF and RP conditions have 
similar linear trend due to the effect of electric field.  
 
 
4.2.3 Total peptide migration in anionic and cationic compartments 
 
The electrodialytic conditions have affected the final concentration of peptides in anionic and 
cationic peptide recovery compartments resulting in difference in migration rates (Figure 4.8 
and 4.9).  
 
 
Figure 4.8 Evolution of peptides concentration in the !!"!  under PEF, DC and RP conditions 
during EDUF treatment at pH 6. !!"! : anionic peptide recovery compartment, DC: 
direct current, PEF: pulsed electric field, RP: reverse polarity. 
 
A linear trend of peptides concentration in A!"!  was attained during the EDUF treatment. It 
was observed that peptides migration under DC condition is relatively higher than PEF and 
RP condition as similar to the trend of conductivity in anionic compartment (Figure 4.7b). 
The migration rate of peptides in anionic recovery compartment under DC, PEF and RP 
condition is presented in Table 4.1. Though the peptides migration rate is larger under DC, 
but PEF and RP showed lower standard deviation. The concentration of peptide in cationic 
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recovery compartment (C!"! ) also increased linearly (Figure 4.9) during the EDUF process. 
The peptide concentration in C!"!  under all conditions is almost similar.  
 
  
 
Figure 4.9 Evolution of peptides concentration in the !!"!  under PEF, DC and RP conditions 
during EDUF treatment at pH 6. !!"! : cationic peptide recovery compartment, DC: 
direct current, PEF: pulsed electric field, RP: reverse polarity 
 
 
It is also clear from Table 4.1 that the migration rates in cationic recovery compartment under 
DC, PEF and RP are almost the same. However, the total migration rate under DC condition 
is higher than PEF and RP with values of 0.69 ± 0.09, 0.51 ± 0.05 and 0.38 ± 0.15 g/m2.h 
respectively. This migration is smaller compared to the literature and work performed 
previously using the EDUF process where Poulin et al. [67] has recorded migration rate of 
3.1, 6.87 and 11.23 g/m2.h for electric field strength of 2.75, 5.5 and 11 V/cm respectively. 
The difference is explained by lower electric field strength used in the present study which 
was 0.7 V/cm. Yet the ratio of migration rate to electric field strength is comparable with the 
previous study in case of continuous current mode. Besides lower electric field strength, the 
cell configuration and MWCO of UFM (100 kDa) with effective surface area of 0.734 m2 
used in this study were different compared to 20 kDa of UFM membrane with effective 
surface area of 0.001 m2 in the previous study. The main reason of lower migration rate can 
be explained by the lower electric field strength as from the previous result it is also justified 
that higher electric field resulted in higher migration rate of peptides. In addition, it is noted 
that overall migration rate in PEF and RP is comparatively lower than in DC. It is possibly 
due to the condition of pulse and pause implemented in PEF which impedes the continuous 
flow of peptides toward oppositely charged electrodes by cutting the electric potential field in 
every 2 seconds. In the case of RP, the polarity was altered at every 2 seconds which could 
possibly induce the backward flow of peptides known as retromigration from respective 
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recovery compartment to feed compartment resulting in lowest migration rate of peptides 
among all three conditions (Suwal et al.2015 thesis).  
 
 
 
 
 
Table 4.1 Peptide migration rates in !!"!  and !!"!  recovery compartment. 
Recovery 
compartment 
Migration rate ( g/m2.h) 
DC PEF RP !!"!  0.44 ± 0.10 0.28 ± 0.05 0.16 ± 0.02 !!"!  0.25 ± 0.00 0.23 ± 0.01 0.23 ± 0.03 
Total 0.69 ± 0.09 0.51 ± 0.05 0.38 ± 0.15 !!"! : anionic peptides recovery compartment !!"! : cationic peptides recovery compartment 
 !!
4.3 Peptide profiles 
4.3.1 Peptides profile & molecular weight of BiPro hydrolysate 
 
Figure 4.10 represents HPLC chromatogram of BiPro before enzymatic hydrolysis. The two 
major peaks ‘a’ and ‘b’ observed at retention times of 78.30 and 79.89 min respectively 
corresponds to ! − !" A and ! − !" B, the two major variants of ! − !" protein in milk 
with respective molecular masses of  18,362.86 Da and 18,276.73 Da [71]. The peak detected 
at retention time of 73 min by HPLC may probably correspond to another milk protein, such 
as !-lactalbumin or bovine serum albumin (BSA) since the purity of BiPro was about 90% 
according to the manufacturer (DAVISCO). 
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Figure 4.10 Chromatogram of initial BiPro ( before enzymatic hydrolysis). 
 
Figure 4.11 illustrates chromatogram of BiPro hydrolysate. BiPro was completely hydrolyzed 
since no peak from native protein is observed when compared with figure 4.10. HPLC 
analysis showed that hydrolysis of BiPro gave 27 major peaks. Furthermore the molecular 
masses of the 27 peaks containing peptides were characterized by MS. Potential peptide 
sequences, location of  sequences, net charge and isoelectric point (pI) presented in Table 2 
were obtained by using tools available on the ExPASy Bioinformatics Resource Portal (Swiss 
Institute of Bioinformatics). A total of 31 peptides were obtained from theoretical tryptic 
hydrolysis of BiPro, where 19 peptides with MW ranging from 572.9 Da to 1249.5 Da were 
derived directly from enzymatic hydrolysis of ! − !" protein. The sequence of 6 peptides 
found to be generated from tryptic hydrolysis of BSA and 6 peptides sequences marked as 
“nd” in Table 4.2 were seemingly not generated from tryptic hydrolysis but supposed to be 
formed due to peptide-peptide interactions or from other protein source, which was already 
observed by Doyen et al. [68], [72].  
 
 
 
 
Figure 4.11 Chromatogram of BiPro hyrdolysate after enzymatic hydrolysis.  
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Table 4.2 Characterization of peptides obtained after 120 min of tryptic hydrolysis of BiPro. 
Peak# Rt (min)a Obs MWb Potential sequence Locationc Net 
charged 
pIe 
1 22.3 617.9 EQLTKg f1-05 nd nd 
2 24.3 804.7 IIAEKTK f71-77 nd nd 
3 25.5 572.9 IIAEK f71-75 − 6.0 
4 27.5 856.7 DAQSAPLR F33-40 − 5.84 
 28.1 700.9 DAQSAPL f33-39 − 3.80 
 29.6 915.7 IDALNENK f84-91 − 4.37 
5 30.4 915.7 ndf nd nd nd 
6 31.6 1043.6 KIDALNENK f83-91 + 6.07 
7 32.9 672.9 GLDIQK f9-14 − 5.84 
8 33.4 948.7 ndf nd nd nd 
9 35.2 1244.5 TPEVDDEALEK f125-135 − 3.8 
10 37.1 1256.5 VLASSARQRLRg f188-198 nd nd 
11 39.4 932.7 LIVTQTMK f1-8 + 8.8 
12 41.0 836.8 ALPMHIR f142-148 + 9.8 
13 42.5 1192.6 VLVLDTDYKK f92-101 − 5.93 
14 43.8 902.8 TKIPAVFK f76-83 + 10.0 
15 44.6 695.7 VAGTWY f15-20 − 5.49 
16 45.7 1064.6 WENGECAQK f61-69 − 4.5 
17 47.5 1007.7 ndf nd nd nd 
18 48.5 2903.5 DVCKNYQEAKDAFLGSFLYE YSRRg f313-336 nd nd 
19 49.5 1162.6 LVNELTEFAKg f42-51 nd  nd 
20 50.4 774.8 TKIPAVF f76-82 + 8.41 
21 51.0 1199.6 ndf nd nd nd 
22 52.9 1249.5 FKDLGEEHFK F35-44 − 5.4 
23 53.6 2306.9 ndf nd nd nd 
 54.7 1013.7 QTALVELLKg f525-533 nd nd 
24 57.8 2028.3 LGEYGFQNALIVRYTRKg f21-40 nd nd 
25 59.5 1156.6 ndf nd nd nd 
 61.0 1190.5 SLAMAASDISLL f21-32 − 3.80 
26 64.4 931.7 KIIAEKTK f70-71  nd    nd 
27 71.4 2704.9 VAGTWYSLAMAASDISLLDAQSAPLR f15-40 − 4.2 
a Retention time 
b Observed molecular weight 
c Peptide location on the mature !-Lg protein 
d Calculated at pH 7.8 
e Isoelectric point 
f Not determined 
g Peptides generated by hydrolysis of bovine serum albumin 
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4.3.2 Profiles of peptides recovered in anionic and cationic recovery compartments 
4.3.2.1 Peptides profile obtained from preliminary test (case III) of EDUF treatment 
 
A typical HPLC chromatogram of peptides fraction obtained in anionic recovery 
compartment after EDUF of 60 min is displayed in Figure 4.12. Among the 11 peaks 
identified in A!"! , 5 peaks (#11, 12, 14, 16, 26) were from the !-Lg source. According to the 
relative area of the peaks, peak #12 and 14 with peptide sequence ALPMHIR and 
TKIPAVFK, respectively appeared higher in area than other peaks.  
 
 
 
 
Figure 4.12 Chromatogram of peptides obtained in anionic peptide recovery compartment 
after 60 min of EDUF treatment.  
 
 
In the chromatogram of peptides fraction in C!"!  (shown in Figure 4.13), 7 peaks were 
identified. It is observed that peak #12 and 14 have markedly migrated in cationic peptides 
recovery compartment than anionic peptides recovery compartment. It might be due to the 
fact of charge of those peptides. Since ALPMHIR and TKIPAVFK were positively charged at 
pH 6 (pI 9.8 for peak #12 and pI 10 for peak #14) which as a result migrated towards cationic 
peptides recovery compartment and hence are larger in quantities compared to that found in A!"! . A markedly migration of peak #12 and 14 could also be facilitated due to the negative 
charge of UFMs which as a result can easily allow to pass a positively charged peptide. 
Secondly, the molecular weight of these peptides (836.8 Da for peak #12 and 902.8 Da for 
peak #14) are lower which allows the cationic peptides to migrate towards C!"! . 
 
Time![min]!
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Figure 4.13 Chromatogram of peptides obtained in cationic peptide recovery compartment 
after  60 min of EDUF treatment.  
 !
4.3.2.2 Peptides profile obtained under the experimental conditions of DC, PEF and RP.  
 
Figure 4.14 showed the HPLC chromatogram of peptides fraction recovered in the anionic 
peptides recovery compartment when treatment was done under DC, PEF and RP conditions. 
Under DC conditions, total of 12 peaks were identified and among which 8 peaks were found 
to be from the !-Lg source. It is observed that peaks #12, 14, 24, 25, 26 and 27 are relatively 
higher in area than other peaks.  
Time![min]!
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Figure 4.14 Chromatogram of peptides obtained in the !!"!  under PEF, DC and RP 
conditions during EDUF treatment at pH 6. !!"! : anionic peptide recovery 
compartment, DC: direct current, PEF: pulsed electric field, RP: reverse 
polarity. 
 
 
HPLC analyses performed on cationic peptides recovered in C!"!  after 60 min EDUF 
treatment at pH 6 under DC, PEF and RP conditions are shown in Figure 4.15. Under DC, 
PEF and RP conditions 14, 15 and 12 peaks were obtained respectively. Although the peaks 
originated from the !-Lg source were 9 peaks from DC, 7 peaks from PEF and 7 peaks from 
RP condition. If the number of peaks obtained is narrowed down to the peaks that 
corresponds to cationic peptides (positively charged peptides) then it is found that 4 peaks of 
cationic peptides sequence are obtained under DC while 3 peaks each are found under PEF 
 Confidential+Report+ + ++++!37 
and RP conditions. It is also observed that 3 peaks of cationic peptides (peak #11, 12, 14) are 
found common whatever is the condition and their peptide sequences are LIVTQTMK, 
ALPMHIR and TKIPAVEK. It is due to the positive charge of these peptides at pH 6 ( pI 8.8 
for #11, pI 9.8 for #12 and pI 10 for #14) and also their relatively lower molecular mass 
932.7, 836.8 and 902.8 Da respectively. However the peptide sequence GLDIQK that 
corresponds to peak # 7 is only noticed in the chromatograms under PEF condition. Besides 
this, peak #11, 12, 14, 16, 24, 26 and 27 under either condition relatively possessed larger 
peak area.  
 
A comparison between the chromatograms of peptides obtained in A!"!  and C!"!  compartment 
under DC, PEF and RP conditions showed almost the similar peaks and peptide sequences. 
Although it is found that few peaks under DC condition (peak #20, 21 and 22) in C!"!  are 
completely missing in A!"! . Similarly, peak #7 and #18 in C!"!   under PEF condition are 
missing from A!"!  and peak #17 and #18 in A!"!  under RP from C!"!  are missing. This can be 
explained due to the larger molecular mass and pI of these peptides.  
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Figure 4.15 Chromatograms of peptides obtained in the !!"!  under PEF, DC and RP 
conditions during EDUF treatment at pH 6. !!"! : cationic peptide recovery 
compartment, DC: direct current, PEF: pulsed electric field, RP: reverse polarity 
 
 
However, the chromatograms of BiPro hydrolysate (shown in Figure 4.11) and peptides 
sequences presented in Table 4.2 showed the presence of bioactive peptides. Amongst 19 
peaks identified from the source of ! − !", 6 peptides had bioactive functionality. Peptide 
sequence IIAEK (peak #3) and GLDIQK (peak #7) were previously identified as 
hypocholestrolemic [39]. Peptide sequence IDALNENK (peak #4) and 
VAGTWYSLAMAASDISLLDAQSAPLR (peak #27) possess antihypertensive function [73] 
and also ALPMHIR (peak #12) was identified as antihypertensive [22]. It was also found that 
peptide sequence VLVLDTDYKK (peak #13) was marked as antibacterial [40]. 
 
 Confidential+Report+ + ++++!39 
 
 
 
 
 
 
 
 ! CHAPTER!5!CONCLUSIONS!AND!FUTURE!PERSPECTIVE!!!!!!!!!!!!!!!!!!!!!!!!
 Confidential+Report+ + ++++!40 
5. Conclusions and Future Perspective 
 
Enzymatic hydrolysis of BiPro has isolated peptides fractions, amongst these 6 were found to 
have bioactive peptides. Separation of bioactive peptides of specific interest (in this case 
peptide sequence ALPMHIR) was studied on pilot-scale EDUF (EUR6) model. Preliminary 
tests were done to establish the pressure flow relation in the different compartments. Later 
EDUF preliminary test investigated the current density at 10V and showed the relation of 
solution conductivity on migration of peptides in the recovery compartments (A!"!  and C!"! ). 
The peptides migration was found relatively higher in A!"!  than C!"!  corresponding to values 
of 196.7 ± 86.7!!"/!" and 84.8 ± 26.9!!"/!" respectively due to higher concentration of 
anionic peptides generated by tryptic hydrolysis of bipro at pH 7.8 or possibly due to less 
peptide-membrane interaction. The study on the effect of three electric field conditions (DC, 
PEF and RP) showed the influence of electrodialytic paramaters on migration rate. Under DC 
condition migration rate was relatively larger with a value of 0.69 ± 0.09 g/m2.h, while 
migration rate dropped by 25% under PEF condition and approximately decreased to 50% 
under RP condition. It was also found that some of the peptides missing under DC were 
observed during PEF and RP condition. This showed that PEF and RP conditions improve the 
selectivity of specific peptides. Besides selectivity of process, the use of PEF and RP as 
electric field conditions have previously reported to improve process performance by 
controlling concentration polarization and mineral fouling on IEM mainly while working with 
food processing [74][60][75].  
 
EUR6 model is the first pilot-scale EDUF configuration used for the fractionation of 
enzymatically generated peptides to our knowledge. It was the first attempt to analyze the 
effect of electrodialytic parameters and also electric field conditions on pilot scale EDUF. 
When compared to results in the literature obtained by using lab-scale EDUF model, the 
migration rates were lower in the present study. The possible reasons for lower migration rate 
of peptides and inefficient separation of anionic and cationic peptides can be discussed by 
explaining the electric field strength, pressure and properties of UFM used in the present 
study. It is true that electric flow is proportional to electric field strength. An electric field 
strength of 0.7 V/cm applied in the current study is considerably low for a pilot-scale model 
and in comparison with previous studies. On the other hand, an applied pressure of 10 psi was 
found to be more dominant than electric field. As a consequence the migration of peptides 
was more governed based on the size of peptides than the charge of peptides. This led to 
decrease in membrane selectivity and it is also further verified by HPLC chromatograms of 
peptides obtained in recovery compartments which had similar peaks. In addition, the 
MWCO of ultrafiltration membranes used in the current study were of 100 kDa and it is 
supposed to be high since the peptides generated from ! − !"  source on enzymatic 
hydrolysis were not larger than 1500 Da.  
 
Besides the MWCO of UFMs, it is also recommended to account the conductivity of the 
membrane since it affects the migration rate of peptides. It will also be interesting to study the 
possible arrangement of EDUF configuration, like number of spacers used and its thickness. 
Furthermore, it is believed that peptides separation can be efficiently achieved using pilot-
scale EDUF in future by optimally controlling: (a) process parameters like electric field 
strength, controlled pressure (no transmembrane pressure), feed concentration, working pH 
and solution conductivity, and (b) membrane properties like MWCO, conductivity and 
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thickness of ultrafiltration membrane. It is expected that industrial reality with EDUF process 
is very promising for the separation of bioactive compounds when process optimization can 
be done.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 !!!!!!!!!
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